Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?

被引：1
作者：
Rossignol, Patrick [1 ,2 ,3 ,4 ,6 ,7 ]
Pitt, Bertram [5 ]
机构：
[1] Univ Lorraine, Inserm, U1116, CHRU Nancy,Ctr Invest Clin Plurithemat 14 33, Nancy, France
[2] F CRIN INI CRCT Cardiovasc & Renal ClinicalTrialis, Nancy, France
[3] Princess Grace Hosp, Med & Nephrol Dialysis Dept, Monaco, Monaco
[4] Monaco Private Hemodialysis Ctr, Monaco, Monaco
[5] Univ Michigan, Sch Med, Ann Arbor, MI USA
[6] Univ Lorraine, Inserm, U1116, CHRU Nancy,Ctr Invest Clin Plurithematique 14 33, 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
[7] F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, 4 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 03期
关键词：
CHRONIC KIDNEY-DISEASE; SAFETY; HEMODIALYSIS; MANAGEMENT; EFFICACY;
D O I：
10.1002/ejhf.2804
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 363
页数：3
相关论文
共 16 条
  • [1] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [2] Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
    Agarwal, Rajiv
    Rossignol, Patrick
    Romero, Alain
    Garza, Dahlia
    Mayo, Martha R.
    Warren, Suzette
    Ma, Jia
    White, William B.
    Williams, Bryan
    [J]. LANCET, 2019, 394 (10208) : 1540 - 1550
  • [3] Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease BLOCK-CKD Trial
    Bakris, George
    Yang, Y. Fred
    Pitt, Bertram
    [J]. HYPERTENSION, 2020, 76 (01) : 144 - 149
  • [4] Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
    Butler, Javed
    Anker, Stefan D.
    Siddiqi, Tariq Jamal
    Coats, Andrew J. S.
    Dorigotti, Fabio
    Filippatos, Gerasimos
    Friede, Tim
    Goehring, Udo-Michael
    Kosiborod, Mikhail N.
    Lund, Lars H.
    Metra, Marco
    Quinn, Carol Moreno
    Pina, Ileana L.
    Pinto, Fausto J.
    Rossignol, Patrick
    Szecsody, Peter
    Van der Meer, Peter
    Weir, Matthew
    Pitt, Bertram
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (01) : 230 - 238
  • [5] Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis A Systematic Review and Meta-Analysis
    Chen, Kuan-Ting
    Kang, Yi-No
    Lin, Yen-Chung
    Tsai, I-Lin
    Chang, Wei-Chiao
    Fang, Te-Chao
    Wu, Mai-Szu
    Kao, Chih-Chin
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (06): : 916 - 925
  • [6] Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
    Freeman, Mason W. W.
    Halvorsen, Yuan-Di
    Marshall, William
    Pater, Mackenzie
    Isaacsohn, Jon
    Pearce, Catherine
    Murphy, Brian
    Alp, Nicholas
    Srivastava, Ajay
    Bhatt, Deepak L. L.
    Brown, Morris J. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05) : 395 - 405
  • [7] The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure
    Lin, Donna Shu-Han
    Lin, Fang-Ju
    Lin, Yu-Sheng
    Lee, Jen-Kuang
    Lin, Yen-Hung
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 98 - 107
  • [8] Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
    Matsumoto, Yoshihiro
    Mori, Yasuo
    Kageyama, Shinji
    Arihara, Kazuo
    Sugiyama, Toshikazu
    Ohmura, Hiromichi
    Yakushigawa, Toru
    Sugiyama, Hatsumi
    Shimada, Yasushi
    Nojima, Youichi
    Shio, Nobuo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 529 - 536
  • [9] Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
    Ortiz, Alberto
    Ferro, Charles J.
    Balafa, Olga
    Burnier, Michel
    Ekart, Robert
    Halimi, Jean-Michel
    Kreutz, Reinhold
    Mark, Patrick B.
    Persu, Alexandre
    Rossignol, Patrick
    Ruilope, Luis M.
    Schmieder, Roland E.
    Valdivielso, Jose M.
    Del Vecchio, Lucia
    Zoccali, Carmine
    Mallamaci, Francesca
    Sarafidis, Pantelis
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 10 - 25
  • [10] Mineralocorticoid Receptor Antagonists in Patients With End-Stage Renal Disease on Chronic Hemodialysis
    Pitt, Bertram
    Rossignol, Patrick
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 537 - 538
12